Prognostic significance of peripheral blood and bone marrow tyrosinase messenger RNA in malignant melanoma

Clinical Cancer Research

Volumn 4, Issue 2, 1998, Pages 419-428

  Ghossein, Ronald A ^a   Coit, Daniel ^a   Brennan, Murray ^a   Zhang, Zuo Feng ^a   Wang, Yan ^a   Bhattacharya, Satyajit ^a   Houghton, Alan ^a   Rosai, Juan ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; MONOPHENOL MONOOXYGENASE;

ADVANCED CANCER; ARTICLE; BLOOD SAMPLING; CANCER STAGING; CANCER SURVIVAL; CELL DIFFERENTIATION; HUMAN; HUMAN TISSUE; MELANOMA; MELANOMA CELL; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE SPECIFICITY;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BONE MARROW; FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; MONOPHENOL MONOOXYGENASE; NEOPLASM METASTASIS; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; PROGNOSIS; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0031889690     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Parker, S. L., Tong, T., Bolden, S., and Wingo, P. A. Cancer statistics, 1997. CA Cancer J. Clin. 47: 5-27, 1997.
2. Battyani, Z., Grob, J. J., Xerri, L., Noe, C., Zarour, H., Houvaeneghel, G., Delpero, J. R., Birmbaum, D., Hassoun, J., and Bonerandi, J. J. Polymerase chain reaction detection of circulating melanocytes as a prognostic marker in patients with melanoma. Arch. Dermatol., 131: 443-447, 1995.
3. Gribben, J. G., and Nadler, L. M. Detection of minimal residual disease in patients with lymphomas using the polymerase chain reaction. In: V. T. DeVita, S. Hellman, and S. A. Rosenberg (eds.), Important Advances in Oncology, pp. 117-129. Philadelphia: J. B. Lippincott Co., 1994.
4. Roth, M. S., Antin, J. H., Ash, R., Terry, V. H., Gotlieb, M., Silver, S. M., and Ginsburg, D. Prognostic significance of Philadelphia chromosome-positive cells detected by the polymerase chain reaction after allogenic bone marrow transplant for chronic myelogenous leukemia. Blood, 79: 276-282, 1992.
5. Ghossein, R. A., Scher, H. I., Gerald, W. L., Kelly, W. K., Curley, T., Amsterdam, A., Zhang, Z. F., and Rosai, J. Detection of circulating tumor cells in patients with localized and metastatic prostatic carcinoma: clinical implications. J. Clin. Oncol., 13: 1195-1200, 1995.
6. Moreno, J. G., Croce, C. M., Fischer, R., Monne, M., Vikho, P., Grant Mulholland, S., and Gomella, L. G. Detection of hematogenous micrometastasis in patients with prostate cancer. Cancer Res., 52: 6110-6112, 1992.
7. Smith, B., Selby, P., Southgate, J., Pittman, K., Bradley, C., and Blair, G. E. Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction. Lancet, 338: 1227-1229, 1991.
8. Mattano, L. A., Moss, T. J., and Emerson, S. G. Sensitive detection of rare circulating tumor neuroblastoma cells by the reverse transcriptase polymerase chain reaction. Cancer Res., 52: 4701-4705, 1992.
9. Kawasaki, E. S., Clark, S. S., Coyne, M. Y., Smith, S. D., Champlin, R., Witte, O. N., and McCormick, F. P. Diagnosis of chronic myeloid and acute lymphocytic leukemias by detection of leukemia-specific mRNA sequences amplified in vitro. Proc. Natl. Acad. Sci. USA, 85: 5698-5702, 1988.
10. Tada, M., Omata, M., Kawai, S., Saisho, H., Ohto, M., Saiki, R. K., and Sninsky, J. J. Detection of ras gene mutations in pancreatic juice and peripheral blood of patients with pancreatic adenocarcinoma. Cancer Res., 53: 2472-2474,1993.
11. Hoon, D. S. B., Wang, Y., Dale, P. S., Conrad, A. J., Schmid, P., Garrison, D., Kuo, C., Foshag, L. J., Nizze, A. J., Morton, D. L. Detection of occult melanoma cells in blood with a multiple-marker polymerase chain reaction assay. J. Clin. Oncol., 13: 2109-2116, 1995.
12. Kunter, U., Buer, J., Probst, M., Duensing, S., Dallmann, I., Grosse, J., Kirshner, H., Schluepen, E. M., Volkenandt, M., Ganger, A., and Atzpodien, J. Peripheral blood tyrosinase messenger RNA detection and survival in malignant melanoma. J. Natl. Cancer Inst., 88: 590-594, 1996.
13. Mellado, B., Colomer, D., Castel, T., Munoz, M., Carballo, E., Galan, M., Mascaro, J. M., Vives-Corrons, J. L., Grau, J. J., and Estape, J. Detection of circulating neoplastic cells by reverse-transcriptase polymerase chain reaction in malignant melanoma: association with clinical stage and prognosis. J. Clin. Oncol., 14: 2091-2097, 1996.
14. Brossart, P., Keilholz, U., Willhauck, M., Scheibenbogen, C., Mohler, T., and Hunstein, W. Hematogenous spread of malignant melanoma cells in different stages of disease. J. Invest. Dermatol., 101: 887-889, 1993.
15. Buzaid, A. C., and Balch, C. M. Polymerase chain reaction for detection of melanoma in peripheral blood: too early to assess clinical value. J. Natl. Cancer Inst., 88: 569-570, 1996.
16. Wang, X., Heller, R., VanVoorhis, N., Cruse, C. W., Glass, F., Fenske, N., Berman, C., Leo-Messina, J., Rappaport, D., Wells, K., Moscinski, L., Standard, C., Puleo, C., and Reintgen, D. Detection of submicroscopic lymph node metastases with polymerase chain reaction in patients with malignant melanoma. Ann. Surg., 220: 768-774, 1994.
17. Van der Velde-Zimmerman, D., Roijers, J. F. M., Bouwens-Rombouts, A., De Weger, R. A., De Graaf, P. W., Tilanus, M. G. J., and Van den Tweel, J. G. Molecular test for the detection of tumor cells in blood and sentinel nodes of melanoma patients. Am. J. Pathol., 149: 759-764, 1996.
18. Beahrs, D. E., Henson, and Hutter, R. V. P. (eds.). Manual for Staging of Cancer, 4th Ed. Philadelphia: J. B. Lippincott Co., 1992.
19. Ben-Ezra, J., Johnson, D. A., Rossi, J., Cook, N., and Wu, A. Effect of fixation on the amplification of nucleic acids from paraffin-embedded material by the polymerase chain reaction. J. Histochem. Cytochem., 39: 351-354, 1991.
20. Kaplan, E. L., and Meier, P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc., 53: 457-481, 1958.
21. Peto, R., Pike, M. C., Armitage, P., Breslow, N. E., Cox, D. R., Howard, S. V., Mantel, N., McPherson, K., Peto, J., and Smith, P. J. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br. J. Cancer, 35: 1-39, 1977.
22. SAS Institute Inc. SAS/STAT User Guide, Version 6. Cary, NC: SAS Institute Inc., 1990.
23. Cox, D. R. Regression models and life tables. J. R. Stat. Soc. Ser. B, 34: 187-220, 1972.
24. Cox, D. R. Partial likelihood. Biometrika, 62: 269-279, 1975.
25. Kaplan, J. C., Kahn, A., and Chelly, J. Illegitimate transcription: its use in the study of inherited disease. Hum. Mutat., 1: 357-360, 1992.
26. Chen, Y. T., Stockert, E., Tsang, S., Coplan, K. A., and Old, L. J. Immunophenotyping of melanomas for tyrosinase: implications for vaccine development. Proc. Natl. Acad. Sci. USA, 92: 8125-8129, 1995.
27. Pittman, K., Burchill, S., Smith, B., Southgate, J., Joffe, J., Gore, M., and Selby, P. Reverse-transcriptase-polymerase chain reaction for expression of tyrosinase to identify malignant melanoma cells in peripheral blood. Ann. Oncol., 7: 297-301, 1996.
28. Foss, A. J. E., Guille, M. J., Occleston, N. L., Hykin, J. L., Hungerford, J. L., and Lightman, S. The detection of melanoma cells in peripheral blood by reverse transcription-polymerase chain reaction. Br. J. Cancer, 72: 155-159, 1995.
29. Weiss, L. Metastatic inefficiency. Adv. Cancer Res., 54: 159-211, 1990.
30. Glaves, D., Huben, R. P., and Weiss, L. Haematogenous dissemination of cells from human renal adenocarcinomas. Br. J. Cancer, 57: 32-35, 1988.
31. Sugarbaker, P. H. Metastatic inefficiency: the scientific basis for resection of liver metastases from colorectal cancer. J. Surg. Oncol., 3: 158-160, 1993.